Department of Obstetrics and Gynaecology, Usmanu Danfodiyo University/Usmanu Danfodiyo University Teaching Hospital, Sokoto, Sokoto State, Nigeria.
Department of Obstetrics and Gynaecology, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Sokoto State,, Nigeria.
Niger Postgrad Med J. 2021 Jul-Sep;28(3):181-186. doi: 10.4103/npmj.npmj_495_21.
Uterine fibroid is the most common benign tumour of the uterus and the exact cause is unknown. Vitamin D has been found to inhibit cell proliferation and enhance apoptosis in vitro.
The aim of this study is to compare the plasma level of Vitamin D among women with uterine fibroids and those without uterine fibroids.
This was an analytical cross-sectional study conducted among women with uterine fibroids and those without uterine fibroids. An interviewer-administered questionnaire was used to obtain relevant information. Five millilitres of venous blood was obtained for plasma Vitamin D assay. Data analysis was performed using the SPSS version 22. Level of significance was set at P < 0.05.
There were 100 participants recruited for the study. The mean age of the participants with uterine fibroid was 35.06 ± 6.6 years and that of controls was 33.28 ± 7 years. The mean plasma level of Vitamin D for all the participants was 12.47 ± 7.53 ng/ml. The mean plasma level of Vitamin D in those with uterine fibroids was significantly lower than in those without uterine fibroid (10.16 ± 7.78 vs. 14.35 ± 6.8; t = 2.517, P = 0.014). It also shows that 1 unit increase in Vitamin D level will reduce the risk of developing uterine fibroids by 8% (odds ratio = 0.92, 95% confidence interval = 0.86-0.99).
The predictors of uterine fibroids were fewer hours spent outdoors, middle social class and low Vitamin D levels.
子宫肌瘤是最常见的子宫良性肿瘤,确切病因不明。维生素 D 已被发现可抑制体外细胞增殖并促进细胞凋亡。
本研究旨在比较子宫肌瘤患者和非子宫肌瘤患者的血浆维生素 D 水平。
这是一项在子宫肌瘤患者和非子宫肌瘤患者中进行的分析性横断面研究。采用问卷调查获取相关信息。采集 5ml 静脉血用于检测血浆维生素 D 水平。使用 SPSS 版本 22 进行数据分析。显著性水平设为 P < 0.05。
研究共纳入 100 名参与者。子宫肌瘤患者的平均年龄为 35.06 ± 6.6 岁,对照组为 33.28 ± 7 岁。所有参与者的平均血浆维生素 D 水平为 12.47 ± 7.53ng/ml。子宫肌瘤患者的平均血浆维生素 D 水平明显低于非子宫肌瘤患者(10.16 ± 7.78 vs. 14.35 ± 6.8;t = 2.517,P = 0.014)。这表明维生素 D 水平每增加 1 单位,患子宫肌瘤的风险就会降低 8%(比值比 = 0.92,95%置信区间 = 0.86-0.99)。
户外活动时间较少、中等社会阶层和低维生素 D 水平是子宫肌瘤的预测因素。